Details der Publikation - Research advances in hydrogen–deuterium exchange mass spectrometry for protein epitope mapping

Research advances in hydrogen–deuterium exchange mass spectrometry for protein epitope mapping

Abstract With the development of biomedical technology, epitope mapping of proteins has become critical for developing and evaluating new protein drugs. The application of hydrogen–deuterium exchange for protein epitope mapping holds great potential. Although several reviews addressed the hydrogen–deuterium exchange, to date, only a few systematic reviews have focused on epitope mapping using this technology. Here, we introduce the basic principles, development history, and review research progress in hydrogen–deuterium exchange epitope mapping technology and discuss its advantages. We summarize the main hurdles in applying hydrogen–deuterium exchange epitope mapping technology, combined with relevant examples to provide specific solutions. We describe the epitope mapping of virus assemblies, disease-associated proteins, and polyclonal antibodies as examples of pattern introduction. Finally, we discuss the outlook of hydrogen–deuterium exchange epitope mapping technology. This review will help researchers studying protein epitopes to gain a more comprehensive understanding of this technology..

Medienart:	E-Artikel

Erscheinungsjahr:	2021
Erschienen:	2021

Enthalten in:	Zur Gesamtaufnahme - volume:413
Enthalten in:	Analytical and bioanalytical chemistry - 413(2021), 9 vom: 06. Jan., Seite 2345-2359

Sprache:	Englisch

Beteiligte Personen:	Sun, Haofeng [VerfasserIn] Ma, Lingyun [VerfasserIn] Wang, Leyu [VerfasserIn] Xiao, Peng [VerfasserIn] Li, Hongmei [VerfasserIn] Zhou, Min [VerfasserIn] Song, Dewei [VerfasserIn]

Links:	Volltext [lizenzpflichtig]

BKL:	35.23$jAnalytische Chemie: Allgemeines 35.71$jBiochemische Methoden 42.03$jMethoden und Techniken der Biologie
Themen:	Antibody Antigen Epitope mapping Hydrogen–deuterium exchange mass spectrometry Protein therapeutics

RVK:	RVK Klassifikation ELIB10

Anmerkungen:	© Springer-Verlag GmbH Germany, part of Springer Nature 2021

doi:	10.1007/s00216-020-03091-9

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	OLC2124546481

Internformat


LEADER	01000naa a22002652 4500
001	OLC2124546481
003	DE-627
005	20230505091135.0
007	cr uuu---uuuuu
008	230505s2021 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1007/s00216-020-03091-9 \|2 doi
035			\|a (DE-627)OLC2124546481
035			\|a (DE-He213)s00216-020-03091-9-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 540 \|a 570 \|q VZ
082	0	4	\|a 540 \|q VZ
084			\|a ELIB10 \|q VZ \|2 rvk
084			\|a 35.23$jAnalytische Chemie: Allgemeines \|2 bkl
084			\|a 35.71$jBiochemische Methoden \|2 bkl
084			\|a 42.03$jMethoden und Techniken der Biologie \|2 bkl
100	1		\|a Sun, Haofeng \|e verfasserin \|4 aut
245	1	0	\|a Research advances in hydrogen–deuterium exchange mass spectrometry for protein epitope mapping
264		1	\|c 2021
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Springer-Verlag GmbH Germany, part of Springer Nature 2021
520			\|a Abstract With the development of biomedical technology, epitope mapping of proteins has become critical for developing and evaluating new protein drugs. The application of hydrogen–deuterium exchange for protein epitope mapping holds great potential. Although several reviews addressed the hydrogen–deuterium exchange, to date, only a few systematic reviews have focused on epitope mapping using this technology. Here, we introduce the basic principles, development history, and review research progress in hydrogen–deuterium exchange epitope mapping technology and discuss its advantages. We summarize the main hurdles in applying hydrogen–deuterium exchange epitope mapping technology, combined with relevant examples to provide specific solutions. We describe the epitope mapping of virus assemblies, disease-associated proteins, and polyclonal antibodies as examples of pattern introduction. Finally, we discuss the outlook of hydrogen–deuterium exchange epitope mapping technology. This review will help researchers studying protein epitopes to gain a more comprehensive understanding of this technology.
650		4	\|a Epitope mapping
650		4	\|a Hydrogen–deuterium exchange mass spectrometry
650		4	\|a Antigen
650		4	\|a Antibody
650		4	\|a Protein therapeutics
700	1		\|a Ma, Lingyun \|4 aut
700	1		\|a Wang, Leyu \|4 aut
700	1		\|a Xiao, Peng \|4 aut
700	1		\|a Li, Hongmei \|4 aut
700	1		\|a Zhou, Min \|4 aut
700	1		\|a Song, Dewei \|4 aut
773	0	8	\|i Enthalten in \|t Analytical and bioanalytical chemistry \|d Springer Berlin Heidelberg, 2002 \|g 413(2021), 9 vom: 06. Jan., Seite 2345-2359 \|h Online-Ressource \|w (DE-627)25372337X \|w (DE-600)1459122-4 \|w (DE-576)072372842 \|x 1618-2650 \|7 nnns
773	1	8	\|g volume:413 \|g year:2021 \|g number:9 \|g day:06 \|g month:01 \|g pages:2345-2359
856	4	0	\|u https://dx.doi.org/10.1007/s00216-020-03091-9 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_OLC
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_30
912			\|a GBV_ILN_31
912			\|a GBV_ILN_32
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_90
912			\|a GBV_ILN_95
912			\|a GBV_ILN_100
912			\|a GBV_ILN_101
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_120
912			\|a GBV_ILN_138
912			\|a GBV_ILN_150
912			\|a GBV_ILN_151
912			\|a GBV_ILN_152
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_171
912			\|a GBV_ILN_187
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_224
912			\|a GBV_ILN_230
912			\|a GBV_ILN_250
912			\|a GBV_ILN_281
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_370
912			\|a GBV_ILN_602
912			\|a GBV_ILN_636
912			\|a GBV_ILN_702
912			\|a GBV_ILN_2001
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2004
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2006
912			\|a GBV_ILN_2007
912			\|a GBV_ILN_2008
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2010
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2015
912			\|a GBV_ILN_2020
912			\|a GBV_ILN_2021
912			\|a GBV_ILN_2025
912			\|a GBV_ILN_2026
912			\|a GBV_ILN_2027
912			\|a GBV_ILN_2031
912			\|a GBV_ILN_2034
912			\|a GBV_ILN_2037
912			\|a GBV_ILN_2038
912			\|a GBV_ILN_2039
912			\|a GBV_ILN_2044
912			\|a GBV_ILN_2048
912			\|a GBV_ILN_2049
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2056
912			\|a GBV_ILN_2057
912			\|a GBV_ILN_2059
912			\|a GBV_ILN_2061
912			\|a GBV_ILN_2064
912			\|a GBV_ILN_2065
912			\|a GBV_ILN_2068
912			\|a GBV_ILN_2088
912			\|a GBV_ILN_2093
912			\|a GBV_ILN_2106
912			\|a GBV_ILN_2107
912			\|a GBV_ILN_2108
912			\|a GBV_ILN_2110
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_2112
912			\|a GBV_ILN_2113
912			\|a GBV_ILN_2118
912			\|a GBV_ILN_2129
912			\|a GBV_ILN_2134
912			\|a GBV_ILN_2143
912			\|a GBV_ILN_2144
912			\|a GBV_ILN_2147
912			\|a GBV_ILN_2148
912			\|a GBV_ILN_2152
912			\|a GBV_ILN_2153
912			\|a GBV_ILN_2188
912			\|a GBV_ILN_2190
912			\|a GBV_ILN_2232
912			\|a GBV_ILN_2336
912			\|a GBV_ILN_2360
912			\|a GBV_ILN_2433
912			\|a GBV_ILN_2446
912			\|a GBV_ILN_2470
912			\|a GBV_ILN_2474
912			\|a GBV_ILN_2507
912			\|a GBV_ILN_2522
912			\|a GBV_ILN_2548
912			\|a GBV_ILN_4035
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4046
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4242
912			\|a GBV_ILN_4246
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4251
912			\|a GBV_ILN_4277
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4326
912			\|a GBV_ILN_4328
912			\|a GBV_ILN_4333
912			\|a GBV_ILN_4334
912			\|a GBV_ILN_4335
912			\|a GBV_ILN_4336
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4393
912			\|a GBV_ILN_4700
936	r	v	\|a ELIB10
936	b	k	\|a 35.23$jAnalytische Chemie: Allgemeines \|q VZ \|0 106417940 \|0 (DE-625)106417940
936	b	k	\|a 35.71$jBiochemische Methoden \|q VZ \|0 106417398 \|0 (DE-625)106417398
936	b	k	\|a 42.03$jMethoden und Techniken der Biologie \|q VZ \|0 10641013X \|0 (DE-625)10641013X
951			\|a AR
952			\|d 413 \|j 2021 \|e 9 \|b 06 \|c 01 \|h 2345-2359

Research advances in hydrogen–deuterium exchange mass spectrometry for protein epitope mapping

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände